[
    {
        "id": 8665,
        "drug_name": "WAINUA (eplontersen)",
        "clinical_trial_id": null,
        "has_trial_insight_page": 0,
        "indication": "Hereditary ATTR Amyloidosis (hATTR)",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2023-12-22",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/AZN\/news\/176762",
        "note": "Approved December 22, 2023.",
        "company_entity_id": 173,
        "company_ticker": "IONS",
        "company_name": "Ionis Pharmaceuticals Inc.",
        "company_price": "43.1700",
        "company_change": -0.08999999999999997,
        "company_percent_change": -0.20999999999999996,
        "company_optionable": 1,
        "company_number_of_shares": 145751797,
        "price_change_sparkline": [
            [
                51.39,
                1706677200
            ],
            [
                50.97,
                1706763600
            ],
            [
                49.75,
                1706850000
            ],
            [
                49.43,
                1707109200
            ],
            [
                49.12,
                1707195600
            ],
            [
                49.54,
                1707282000
            ],
            [
                49.98,
                1707368400
            ],
            [
                51.4,
                1707454800
            ],
            [
                50.38,
                1707714000
            ],
            [
                48.61,
                1707800400
            ],
            [
                49.07,
                1707886800
            ],
            [
                45.28,
                1707973200
            ],
            [
                44.43,
                1708059600
            ],
            [
                44.35,
                1708405200
            ],
            [
                43.53,
                1708491600
            ],
            [
                43.98,
                1708578000
            ],
            [
                45.36,
                1708664400
            ],
            [
                46.1,
                1708923600
            ],
            [
                47.41,
                1709010000
            ],
            [
                46.54,
                1709096400
            ],
            [
                45.21,
                1709182800
            ],
            [
                45.46,
                1709269200
            ],
            [
                44.87,
                1709528400
            ],
            [
                44.19,
                1709614800
            ],
            [
                44.29,
                1709701200
            ],
            [
                44.67,
                1709787600
            ],
            [
                43.99,
                1709874000
            ],
            [
                43.26,
                1710129600
            ],
            [
                43.17,
                1710216000
            ]
        ],
        "statuses": [
            {
                "label": "Orphan Drug Designation (ODD)",
                "abbreviation": "ODD",
                "description": "Orphan Drug Designation (ODD)",
                "description_html": "<p>Orphan Drug Designation (ODD)<\/p>\n"
            }
        ]
    },
    {
        "id": 9992,
        "drug_name": "ELEVIDYS (SRP-9001-301) - (EMBARK)",
        "clinical_trial_id": null,
        "has_trial_insight_page": 0,
        "indication": "Duchenne muscular dystrophy",
        "label": "BLA Filing",
        "value": "blaFiling",
        "simplified_stage": "phase4",
        "stageid": 12,
        "stage_name": "BLA Filing",
        "date": "2023-12-22",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/SRPT\/news\/176786",
        "note": "BLA submitted to the FDA based on results of EMBARK study, noted December 22, 2023.",
        "company_entity_id": 536,
        "company_ticker": "RHHBY",
        "company_name": "Roche Holding AG ADR",
        "company_price": "35.1500",
        "company_change": 0.54,
        "company_percent_change": 1.56,
        "company_optionable": 0,
        "company_number_of_shares": 6389213336,
        "price_change_sparkline": [
            [
                35.14,
                1706677200
            ],
            [
                34.32,
                1706763600
            ],
            [
                33.95,
                1706850000
            ],
            [
                33.16,
                1707109200
            ],
            [
                33.27,
                1707195600
            ],
            [
                32.55,
                1707282000
            ],
            [
                32.1,
                1707368400
            ],
            [
                32.31,
                1707454800
            ],
            [
                32.6,
                1707714000
            ],
            [
                32.13,
                1707800400
            ],
            [
                32.02,
                1707886800
            ],
            [
                32.1,
                1707973200
            ],
            [
                32.28,
                1708059600
            ],
            [
                32.74,
                1708405200
            ],
            [
                32.91,
                1708491600
            ],
            [
                32.49,
                1708578000
            ],
            [
                32.96,
                1708664400
            ],
            [
                32.52,
                1708923600
            ],
            [
                33.03,
                1709010000
            ],
            [
                32.93,
                1709096400
            ],
            [
                32.73,
                1709182800
            ],
            [
                33.08,
                1709269200
            ],
            [
                32.88,
                1709528400
            ],
            [
                33.15,
                1709614800
            ],
            [
                33.47,
                1709701200
            ],
            [
                33.77,
                1709787600
            ],
            [
                33.9,
                1709874000
            ],
            [
                34.61,
                1710129600
            ],
            [
                35.15,
                1710216000
            ]
        ],
        "statuses": [
            {
                "label": "Fast Track Designation (FTD)",
                "abbreviation": "FTD",
                "description": "Fast Track Designation (FTD)",
                "description_html": "<p>Fast Track Designation (FTD)<\/p>\n"
            }
        ]
    },
    {
        "id": 9992,
        "drug_name": "ELEVIDYS (SRP-9001-301) - (EMBARK)",
        "clinical_trial_id": null,
        "has_trial_insight_page": 0,
        "indication": "Duchenne muscular dystrophy",
        "label": "BLA Filing",
        "value": "blaFiling",
        "simplified_stage": "phase4",
        "stageid": 12,
        "stage_name": "BLA Filing",
        "date": "2023-12-22",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/SRPT\/news\/176786",
        "note": "BLA submitted to the FDA based on results of EMBARK study, noted December 22, 2023.",
        "company_entity_id": 285,
        "company_ticker": "SRPT",
        "company_name": "Sarepta Therapeutics Inc.",
        "company_price": "122.0000",
        "company_change": 0.42,
        "company_percent_change": 0.35,
        "company_optionable": 1,
        "company_number_of_shares": 93855410,
        "price_change_sparkline": [
            [
                118.99,
                1706677200
            ],
            [
                122.83,
                1706763600
            ],
            [
                121.27,
                1706850000
            ],
            [
                125.55,
                1707109200
            ],
            [
                126.41,
                1707195600
            ],
            [
                126.05,
                1707282000
            ],
            [
                127.38,
                1707368400
            ],
            [
                126.87,
                1707454800
            ],
            [
                127.32,
                1707714000
            ],
            [
                124.19,
                1707800400
            ],
            [
                124.3,
                1707886800
            ],
            [
                124.89,
                1707973200
            ],
            [
                134.61,
                1708059600
            ],
            [
                136.14,
                1708405200
            ],
            [
                132.29,
                1708491600
            ],
            [
                134.78,
                1708578000
            ],
            [
                136.53,
                1708664400
            ],
            [
                137.65,
                1708923600
            ],
            [
                141.53,
                1709010000
            ],
            [
                137.5,
                1709096400
            ],
            [
                127.9,
                1709182800
            ],
            [
                128.67,
                1709269200
            ],
            [
                123.88,
                1709528400
            ],
            [
                122.85,
                1709614800
            ],
            [
                120.31,
                1709701200
            ],
            [
                120.78,
                1709787600
            ],
            [
                124.37,
                1709874000
            ],
            [
                121.58,
                1710129600
            ],
            [
                122,
                1710216000
            ]
        ],
        "statuses": [
            {
                "label": "Fast Track Designation (FTD)",
                "abbreviation": "FTD",
                "description": "Fast Track Designation (FTD)",
                "description_html": "<p>Fast Track Designation (FTD)<\/p>\n"
            }
        ]
    },
    {
        "id": 6832,
        "drug_name": "Etripamil - (RAPID)",
        "clinical_trial_id": "NCT03464019",
        "has_trial_insight_page": 1,
        "indication": "Paroxysmal supraventricular tachycardia (PSVT)",
        "label": "NDA Filing",
        "value": "ndaFiling",
        "simplified_stage": "phase4",
        "stageid": 10,
        "stage_name": "NDA Filing",
        "date": "2023-12-26",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/MIST\/news\/176964",
        "note": "FDA issued a Refusal to File (RTF) letter upon preliminary review; the FDA determined that the NDA submitted in October 2023 was not sufficiently complete to permit substantive review, noted December 26, 2023.",
        "company_entity_id": 662,
        "company_ticker": "MIST",
        "company_name": "Milestone Pharmaceuticals Inc.",
        "company_price": "1.4850",
        "company_change": -0.06000000000000005,
        "company_percent_change": -3.57,
        "company_optionable": 1,
        "company_number_of_shares": 33483111,
        "price_change_sparkline": [
            [
                1.6,
                1706677200
            ],
            [
                1.67,
                1706763600
            ],
            [
                1.63,
                1706850000
            ],
            [
                1.59,
                1707109200
            ],
            [
                1.575,
                1707195600
            ],
            [
                1.54,
                1707282000
            ],
            [
                1.64,
                1707368400
            ],
            [
                1.6,
                1707454800
            ],
            [
                1.63,
                1707714000
            ],
            [
                1.55,
                1707800400
            ],
            [
                1.52,
                1707886800
            ],
            [
                1.59,
                1707973200
            ],
            [
                1.53,
                1708059600
            ],
            [
                1.5,
                1708405200
            ],
            [
                1.58,
                1708491600
            ],
            [
                1.62,
                1708578000
            ],
            [
                1.7,
                1708664400
            ],
            [
                2.11,
                1708923600
            ],
            [
                2.2,
                1709010000
            ],
            [
                2.13,
                1709096400
            ],
            [
                1.68,
                1709182800
            ],
            [
                1.61,
                1709269200
            ],
            [
                1.55,
                1709528400
            ],
            [
                1.58,
                1709614800
            ],
            [
                1.45,
                1709701200
            ],
            [
                1.5,
                1709787600
            ],
            [
                1.51,
                1709874000
            ],
            [
                1.54,
                1710129600
            ],
            [
                1.485,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 10704,
        "drug_name": "UDENYCA ONBODY",
        "clinical_trial_id": null,
        "has_trial_insight_page": 0,
        "indication": "Cancer",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2023-12-26",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/CHRS\/news\/177037",
        "note": "FDA approved on December 26, 2023.",
        "company_entity_id": 89,
        "company_ticker": "CHRS",
        "company_name": "Coherus BioSciences Inc.",
        "company_price": "2.2400",
        "company_change": -0.030000000000000027,
        "company_percent_change": -1.3199999999999998,
        "company_optionable": 1,
        "company_number_of_shares": 111364152,
        "price_change_sparkline": [
            [
                2.15,
                1706677200
            ],
            [
                2.09,
                1706763600
            ],
            [
                2.06,
                1706850000
            ],
            [
                2.02,
                1707109200
            ],
            [
                2.32,
                1707195600
            ],
            [
                2.32,
                1707282000
            ],
            [
                2.38,
                1707368400
            ],
            [
                2.62,
                1707454800
            ],
            [
                2.82,
                1707714000
            ],
            [
                2.56,
                1707800400
            ],
            [
                2.72,
                1707886800
            ],
            [
                2.85,
                1707973200
            ],
            [
                2.76,
                1708059600
            ],
            [
                2.59,
                1708405200
            ],
            [
                2.48,
                1708491600
            ],
            [
                2.47,
                1708578000
            ],
            [
                2.58,
                1708664400
            ],
            [
                2.5,
                1708923600
            ],
            [
                2.62,
                1709010000
            ],
            [
                2.36,
                1709096400
            ],
            [
                2.28,
                1709182800
            ],
            [
                2.41,
                1709269200
            ],
            [
                2.27,
                1709528400
            ],
            [
                2.18,
                1709614800
            ],
            [
                2.21,
                1709701200
            ],
            [
                2.21,
                1709787600
            ],
            [
                2.39,
                1709874000
            ],
            [
                2.27,
                1710129600
            ],
            [
                2.24,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 10992,
        "drug_name": "Revumenib",
        "clinical_trial_id": null,
        "has_trial_insight_page": 0,
        "indication": "Adult and pediatric relapsed or refractory (R\/R) KMT2A-rearranged (KMT2Ar) acute leukemia",
        "label": "NDA Filing",
        "value": "ndaFiling",
        "simplified_stage": "phase4",
        "stageid": 10,
        "stage_name": "NDA Filing",
        "date": "2023-12-29",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/SNDX\/news\/177499",
        "note": "NDA submitted to the FDA under  Real-time Oncology Review (RTOR) program, noted December 29, 2023.",
        "company_entity_id": 343,
        "company_ticker": "SNDX",
        "company_name": "Syndax Pharmaceuticals Inc.",
        "company_price": "23.8600",
        "company_change": 0.29,
        "company_percent_change": 1.23,
        "company_optionable": 1,
        "company_number_of_shares": 84965486,
        "price_change_sparkline": [
            [
                20.49,
                1706677200
            ],
            [
                21.24,
                1706763600
            ],
            [
                20.59,
                1706850000
            ],
            [
                21.29,
                1707109200
            ],
            [
                22.63,
                1707195600
            ],
            [
                22.28,
                1707282000
            ],
            [
                22,
                1707368400
            ],
            [
                22.1,
                1707454800
            ],
            [
                22.69,
                1707714000
            ],
            [
                21.22,
                1707800400
            ],
            [
                21.99,
                1707886800
            ],
            [
                22.67,
                1707973200
            ],
            [
                22.47,
                1708059600
            ],
            [
                22.87,
                1708405200
            ],
            [
                22.23,
                1708491600
            ],
            [
                22.71,
                1708578000
            ],
            [
                23.13,
                1708664400
            ],
            [
                24.375,
                1708923600
            ],
            [
                24.41,
                1709010000
            ],
            [
                23.88,
                1709096400
            ],
            [
                23.44,
                1709182800
            ],
            [
                23.71,
                1709269200
            ],
            [
                23.3,
                1709528400
            ],
            [
                22.94,
                1709614800
            ],
            [
                23.75,
                1709701200
            ],
            [
                23.47,
                1709787600
            ],
            [
                24.57,
                1709874000
            ],
            [
                23.57,
                1710129600
            ],
            [
                23.86,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 9895,
        "drug_name": "Axatilimab - (AGAVE-201)",
        "clinical_trial_id": "NCT04710576",
        "has_trial_insight_page": 0,
        "indication": "Chronic Graft versus host disease (cGvHD)",
        "label": "BLA Filing",
        "value": "blaFiling",
        "simplified_stage": "phase4",
        "stageid": 12,
        "stage_name": "BLA Filing",
        "date": "2024-01-02",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/SNDX\/news\/177499",
        "note": "BLA submitteed to the FDA, noted January 2, 2024.",
        "company_entity_id": 343,
        "company_ticker": "SNDX",
        "company_name": "Syndax Pharmaceuticals Inc.",
        "company_price": "23.8600",
        "company_change": 0.29,
        "company_percent_change": 1.23,
        "company_optionable": 1,
        "company_number_of_shares": 84965486,
        "price_change_sparkline": [
            [
                20.49,
                1706677200
            ],
            [
                21.24,
                1706763600
            ],
            [
                20.59,
                1706850000
            ],
            [
                21.29,
                1707109200
            ],
            [
                22.63,
                1707195600
            ],
            [
                22.28,
                1707282000
            ],
            [
                22,
                1707368400
            ],
            [
                22.1,
                1707454800
            ],
            [
                22.69,
                1707714000
            ],
            [
                21.22,
                1707800400
            ],
            [
                21.99,
                1707886800
            ],
            [
                22.67,
                1707973200
            ],
            [
                22.47,
                1708059600
            ],
            [
                22.87,
                1708405200
            ],
            [
                22.23,
                1708491600
            ],
            [
                22.71,
                1708578000
            ],
            [
                23.13,
                1708664400
            ],
            [
                24.375,
                1708923600
            ],
            [
                24.41,
                1709010000
            ],
            [
                23.88,
                1709096400
            ],
            [
                23.44,
                1709182800
            ],
            [
                23.71,
                1709269200
            ],
            [
                23.3,
                1709528400
            ],
            [
                22.94,
                1709614800
            ],
            [
                23.75,
                1709701200
            ],
            [
                23.47,
                1709787600
            ],
            [
                24.57,
                1709874000
            ],
            [
                23.57,
                1710129600
            ],
            [
                23.86,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 9895,
        "drug_name": "Axatilimab - (AGAVE-201)",
        "clinical_trial_id": "NCT04710576",
        "has_trial_insight_page": 0,
        "indication": "Chronic Graft versus host disease (cGvHD)",
        "label": "BLA Filing",
        "value": "blaFiling",
        "simplified_stage": "phase4",
        "stageid": 12,
        "stage_name": "BLA Filing",
        "date": "2024-01-02",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/SNDX\/news\/177499",
        "note": "BLA submitteed to the FDA, noted January 2, 2024.",
        "company_entity_id": 167,
        "company_ticker": "INCY",
        "company_name": "Incyte Corporation",
        "company_price": "59.3300",
        "company_change": -1.46,
        "company_percent_change": -2.4,
        "company_optionable": 1,
        "company_number_of_shares": 224526128,
        "price_change_sparkline": [
            [
                58.77,
                1706677200
            ],
            [
                59.16,
                1706763600
            ],
            [
                58.35,
                1706850000
            ],
            [
                58.06,
                1707109200
            ],
            [
                59.63,
                1707195600
            ],
            [
                57.34,
                1707282000
            ],
            [
                57.36,
                1707368400
            ],
            [
                57.66,
                1707454800
            ],
            [
                57.84,
                1707714000
            ],
            [
                59.34,
                1707800400
            ],
            [
                57.89,
                1707886800
            ],
            [
                58.97,
                1707973200
            ],
            [
                57.96,
                1708059600
            ],
            [
                58.82,
                1708405200
            ],
            [
                60.33,
                1708491600
            ],
            [
                60.91,
                1708578000
            ],
            [
                60.59,
                1708664400
            ],
            [
                60.53,
                1708923600
            ],
            [
                61,
                1709010000
            ],
            [
                59.98,
                1709096400
            ],
            [
                58.36,
                1709182800
            ],
            [
                59.05,
                1709269200
            ],
            [
                59.72,
                1709528400
            ],
            [
                58.9,
                1709614800
            ],
            [
                59.26,
                1709701200
            ],
            [
                59.03,
                1709787600
            ],
            [
                60.02,
                1709874000
            ],
            [
                60.79,
                1710129600
            ],
            [
                59.33,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 9664,
        "drug_name": "DFD-29 - (MVOR-2)",
        "clinical_trial_id": "NCT05452785",
        "has_trial_insight_page": 0,
        "indication": "Papulopustular Rosacea",
        "label": "NDA Filing",
        "value": "ndaFiling",
        "simplified_stage": "phase4",
        "stageid": 10,
        "stage_name": "NDA Filing",
        "date": "2024-01-05",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/FBIO\/news\/178480",
        "note": "NDA submitted to the FDA, noted January 5, 2024.",
        "company_entity_id": 140,
        "company_ticker": "FBIO",
        "company_name": "Fortress Biotech Inc.",
        "company_price": "1.9250",
        "company_change": -0.07999999999999996,
        "company_percent_change": -3.75,
        "company_optionable": 1,
        "company_number_of_shares": 18376750,
        "price_change_sparkline": [
            [
                2.04,
                1706677200
            ],
            [
                1.97,
                1706763600
            ],
            [
                1.85,
                1706850000
            ],
            [
                1.72,
                1707109200
            ],
            [
                1.72,
                1707195600
            ],
            [
                1.75,
                1707282000
            ],
            [
                1.8,
                1707368400
            ],
            [
                1.87,
                1707454800
            ],
            [
                1.92,
                1707714000
            ],
            [
                1.77,
                1707800400
            ],
            [
                1.88,
                1707886800
            ],
            [
                1.88,
                1707973200
            ],
            [
                1.86,
                1708059600
            ],
            [
                1.78,
                1708405200
            ],
            [
                1.73,
                1708491600
            ],
            [
                1.75,
                1708578000
            ],
            [
                1.74,
                1708664400
            ],
            [
                1.85,
                1708923600
            ],
            [
                1.98,
                1709010000
            ],
            [
                2.18,
                1709096400
            ],
            [
                2.08,
                1709182800
            ],
            [
                2.43,
                1709269200
            ],
            [
                2.29,
                1709528400
            ],
            [
                2.27,
                1709614800
            ],
            [
                2.215,
                1709701200
            ],
            [
                2.07,
                1709787600
            ],
            [
                2.1,
                1709874000
            ],
            [
                2,
                1710129600
            ],
            [
                1.925,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 9664,
        "drug_name": "DFD-29 - (MVOR-2)",
        "clinical_trial_id": "NCT05452785",
        "has_trial_insight_page": 0,
        "indication": "Papulopustular Rosacea",
        "label": "NDA Filing",
        "value": "ndaFiling",
        "simplified_stage": "phase4",
        "stageid": 10,
        "stage_name": "NDA Filing",
        "date": "2024-01-05",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/FBIO\/news\/178480",
        "note": "NDA submitted to the FDA, noted January 5, 2024.",
        "company_entity_id": 1517,
        "company_ticker": "DERM",
        "company_name": "Journey Medical Corporation",
        "company_price": "3.4800",
        "company_change": 0.11,
        "company_percent_change": 3.26,
        "company_optionable": 0,
        "company_number_of_shares": 18508449,
        "price_change_sparkline": [
            [
                4.85,
                1706677200
            ],
            [
                4.51,
                1706763600
            ],
            [
                4.82,
                1706850000
            ],
            [
                4.57,
                1707109200
            ],
            [
                4.37,
                1707195600
            ],
            [
                4.57,
                1707282000
            ],
            [
                4.75,
                1707368400
            ],
            [
                4.97,
                1707454800
            ],
            [
                4.95,
                1707714000
            ],
            [
                4.5,
                1707800400
            ],
            [
                4.46,
                1707886800
            ],
            [
                4.4,
                1707973200
            ],
            [
                4.26,
                1708059600
            ],
            [
                3.73,
                1708405200
            ],
            [
                3.76,
                1708491600
            ],
            [
                3.75,
                1708578000
            ],
            [
                3.65,
                1708664400
            ],
            [
                3.77,
                1708923600
            ],
            [
                4.06,
                1709010000
            ],
            [
                3.65,
                1709096400
            ],
            [
                3.95,
                1709182800
            ],
            [
                4.13,
                1709269200
            ],
            [
                4,
                1709528400
            ],
            [
                3.73,
                1709614800
            ],
            [
                3.49,
                1709701200
            ],
            [
                3.47,
                1709787600
            ],
            [
                3.45,
                1709874000
            ],
            [
                3.37,
                1710129600
            ],
            [
                3.48,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 4453,
        "drug_name": "ZELSUVMI (berdazimer topical gel)",
        "clinical_trial_id": "NCT04535531",
        "has_trial_insight_page": 0,
        "indication": "Molluscum Contagiosum",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2024-01-05",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/LGND\/news\/178577",
        "note": "FDA Approved on January 5, 2023.",
        "company_entity_id": 354,
        "company_ticker": "NOVN",
        "company_name": "Novan Inc.",
        "company_price": "0.0941",
        "company_change": 0,
        "company_percent_change": 0,
        "company_optionable": 0,
        "company_number_of_shares": 28015371,
        "price_change_sparkline": [
            [
                0.0001,
                1706677200
            ],
            [
                0.0001,
                1706763600
            ],
            [
                0.0001,
                1706850000
            ],
            [
                0.0001,
                1707109200
            ],
            [
                0.0001,
                1707195600
            ],
            [
                0.0001,
                1707282000
            ],
            [
                0.0001,
                1707368400
            ],
            [
                0.0001,
                1707454800
            ],
            [
                0.0001,
                1707714000
            ],
            [
                0.0001,
                1707800400
            ],
            [
                0.0001,
                1707886800
            ],
            [
                0.0001,
                1707973200
            ],
            [
                0.0001,
                1708059600
            ],
            [
                0.0001,
                1708405200
            ],
            [
                0.005,
                1708491600
            ],
            [
                0.0005,
                1708578000
            ],
            [
                0.0008,
                1708664400
            ],
            [
                0.0008,
                1708923600
            ],
            [
                0.0009,
                1709010000
            ],
            [
                0.0008,
                1709096400
            ],
            [
                0.0008,
                1709182800
            ],
            [
                0.0008,
                1709269200
            ],
            [
                0.0008,
                1709528400
            ],
            [
                0.0008,
                1709614800
            ],
            [
                0.0008,
                1709701200
            ],
            [
                0.0008,
                1709787600
            ],
            [
                0.0008,
                1709874000
            ],
            [
                0.0008,
                1710129600
            ],
            [
                0.0008,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 4453,
        "drug_name": "ZELSUVMI (berdazimer topical gel)",
        "clinical_trial_id": "NCT04535531",
        "has_trial_insight_page": 0,
        "indication": "Molluscum Contagiosum",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2024-01-05",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/LGND\/news\/178577",
        "note": "FDA Approved on January 5, 2023.",
        "company_entity_id": 627,
        "company_ticker": "LGND",
        "company_name": "Ligand Pharmaceuticals Incorporated",
        "company_price": "72.3600",
        "company_change": 0.11,
        "company_percent_change": 0.15,
        "company_optionable": 1,
        "company_number_of_shares": 17705287,
        "price_change_sparkline": [
            [
                73.1,
                1706677200
            ],
            [
                74.17,
                1706763600
            ],
            [
                74.54,
                1706850000
            ],
            [
                74.72,
                1707109200
            ],
            [
                75.31,
                1707195600
            ],
            [
                74.51,
                1707282000
            ],
            [
                75.41,
                1707368400
            ],
            [
                75.88,
                1707454800
            ],
            [
                75.64,
                1707714000
            ],
            [
                71,
                1707800400
            ],
            [
                73.62,
                1707886800
            ],
            [
                74.65,
                1707973200
            ],
            [
                73.66,
                1708059600
            ],
            [
                72.37,
                1708405200
            ],
            [
                72.67,
                1708491600
            ],
            [
                73.56,
                1708578000
            ],
            [
                75.87,
                1708664400
            ],
            [
                74.42,
                1708923600
            ],
            [
                89.2,
                1709010000
            ],
            [
                84.35,
                1709096400
            ],
            [
                79.35,
                1709182800
            ],
            [
                78.7,
                1709269200
            ],
            [
                76.28,
                1709528400
            ],
            [
                74,
                1709614800
            ],
            [
                72.71,
                1709701200
            ],
            [
                72.47,
                1709787600
            ],
            [
                73.77,
                1709874000
            ],
            [
                72.25,
                1710129600
            ],
            [
                72.36,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 7089,
        "drug_name": "NexoBrid (CIDS)",
        "clinical_trial_id": null,
        "has_trial_insight_page": 0,
        "indication": "Severe burns - pediatric",
        "label": "BLA Filing",
        "value": "blaFiling",
        "simplified_stage": "phase4",
        "stageid": 12,
        "stage_name": "BLA Filing",
        "date": "2024-01-09",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/MDWD\/news\/179148",
        "note": "sBLA filing review and accepted by the FDA, noted January 9, 2024.",
        "company_entity_id": 194,
        "company_ticker": "MDWD",
        "company_name": "MediWound Ltd.",
        "company_price": "15.9200",
        "company_change": -0.35,
        "company_percent_change": -2.15,
        "company_optionable": 1,
        "company_number_of_shares": 7240020,
        "price_change_sparkline": [
            [
                12.77,
                1706677200
            ],
            [
                12.67,
                1706763600
            ],
            [
                12.32,
                1706850000
            ],
            [
                11.25,
                1707109200
            ],
            [
                11.27,
                1707195600
            ],
            [
                12.16,
                1707282000
            ],
            [
                12.14,
                1707368400
            ],
            [
                11.9,
                1707454800
            ],
            [
                12.46,
                1707714000
            ],
            [
                12.73,
                1707800400
            ],
            [
                12.74,
                1707886800
            ],
            [
                13.08,
                1707973200
            ],
            [
                13.07,
                1708059600
            ],
            [
                13.12,
                1708405200
            ],
            [
                13.25,
                1708491600
            ],
            [
                13.26,
                1708578000
            ],
            [
                13.4,
                1708664400
            ],
            [
                14,
                1708923600
            ],
            [
                14.68,
                1709010000
            ],
            [
                14.37,
                1709096400
            ],
            [
                14.46,
                1709182800
            ],
            [
                14.2,
                1709269200
            ],
            [
                14.4,
                1709528400
            ],
            [
                15.42,
                1709614800
            ],
            [
                16.58,
                1709701200
            ],
            [
                16.92,
                1709787600
            ],
            [
                17.11,
                1709874000
            ],
            [
                16.27,
                1710129600
            ],
            [
                15.92,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 10511,
        "drug_name": "KEYTRUDA  with external beam radiotherapy (EBRT) plus concurrent chemotherapy - (KEYNOTE-A18)",
        "clinical_trial_id": null,
        "has_trial_insight_page": 0,
        "indication": "Cervical cancer",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2024-01-12",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/MRK\/news\/179946",
        "note": "FDA Approved on January 12, 2024.",
        "company_entity_id": 383,
        "company_ticker": "MRK",
        "company_name": "Merck & Company Inc.",
        "company_price": "122.6600",
        "company_change": -0.10999999999999999,
        "company_percent_change": -0.08999999999999997,
        "company_optionable": 1,
        "company_number_of_shares": 2532643872,
        "price_change_sparkline": [
            [
                120.78,
                1706677200
            ],
            [
                126.38,
                1706763600
            ],
            [
                126.41,
                1706850000
            ],
            [
                126.18,
                1707109200
            ],
            [
                126.88,
                1707195600
            ],
            [
                127.47,
                1707282000
            ],
            [
                126.61,
                1707368400
            ],
            [
                125.45,
                1707454800
            ],
            [
                125.34,
                1707714000
            ],
            [
                125.43,
                1707800400
            ],
            [
                125.82,
                1707886800
            ],
            [
                126.54,
                1707973200
            ],
            [
                127.79,
                1708059600
            ],
            [
                127.37,
                1708405200
            ],
            [
                128.12,
                1708491600
            ],
            [
                129.26,
                1708578000
            ],
            [
                129.45,
                1708664400
            ],
            [
                128.84,
                1708923600
            ],
            [
                129.03,
                1709010000
            ],
            [
                128.19,
                1709096400
            ],
            [
                127.15,
                1709182800
            ],
            [
                126.96,
                1709269200
            ],
            [
                124.05,
                1709528400
            ],
            [
                122.83,
                1709614800
            ],
            [
                123.75,
                1709701200
            ],
            [
                123.99,
                1709787600
            ],
            [
                123.5,
                1709874000
            ],
            [
                122.77,
                1710129600
            ],
            [
                122.66,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 11115,
        "drug_name": "Indomethacin Oral Suspension - (Indocin generic)",
        "clinical_trial_id": null,
        "has_trial_insight_page": 0,
        "indication": "Rheumatoid arthritis, ankylosing spondylitis, osteoarthritis, acute gouty arthritis, bursitis, and tendinitis",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2024-01-16",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/ANIP\/news\/180098",
        "note": "Approved January 16, 2024.",
        "company_entity_id": 792,
        "company_ticker": "ANIP",
        "company_name": "ANI Pharmaceuticals Inc.",
        "company_price": "66.5400",
        "company_change": 0.41,
        "company_percent_change": 0.62,
        "company_optionable": 1,
        "company_number_of_shares": 21078986,
        "price_change_sparkline": [
            [
                55.82,
                1706677200
            ],
            [
                56.51,
                1706763600
            ],
            [
                55.42,
                1706850000
            ],
            [
                56.04,
                1707109200
            ],
            [
                56.87,
                1707195600
            ],
            [
                56.03,
                1707282000
            ],
            [
                55.91,
                1707368400
            ],
            [
                56.51,
                1707454800
            ],
            [
                57.03,
                1707714000
            ],
            [
                55.02,
                1707800400
            ],
            [
                56.1,
                1707886800
            ],
            [
                57.55,
                1707973200
            ],
            [
                59.72,
                1708059600
            ],
            [
                58.37,
                1708405200
            ],
            [
                57.63,
                1708491600
            ],
            [
                58.15,
                1708578000
            ],
            [
                59.13,
                1708664400
            ],
            [
                60.25,
                1708923600
            ],
            [
                59.94,
                1709010000
            ],
            [
                60.28,
                1709096400
            ],
            [
                67.67,
                1709182800
            ],
            [
                67.17,
                1709269200
            ],
            [
                66.42,
                1709528400
            ],
            [
                65.34,
                1709614800
            ],
            [
                65.81,
                1709701200
            ],
            [
                66.71,
                1709787600
            ],
            [
                67.42,
                1709874000
            ],
            [
                66.13,
                1710129600
            ],
            [
                66.54,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 9578,
        "drug_name": "HYQVIA (Immune Globulin Infusion 10% with Recombinant Human Hyaluronidase)",
        "clinical_trial_id": "NCT02549170",
        "has_trial_insight_page": 0,
        "indication": "Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP)",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2024-01-16",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/TAK\/news\/180149",
        "note": "Approved January 16, 2024.",
        "company_entity_id": 156,
        "company_ticker": "HALO",
        "company_name": "Halozyme Therapeutics Inc.",
        "company_price": "41.9500",
        "company_change": 0.75,
        "company_percent_change": 1.8199999999999998,
        "company_optionable": 1,
        "company_number_of_shares": 126824800,
        "price_change_sparkline": [
            [
                33.85,
                1706677200
            ],
            [
                34.26,
                1706763600
            ],
            [
                33.68,
                1706850000
            ],
            [
                33.68,
                1707109200
            ],
            [
                35.02,
                1707195600
            ],
            [
                35.31,
                1707282000
            ],
            [
                35.24,
                1707368400
            ],
            [
                35.49,
                1707454800
            ],
            [
                35.69,
                1707714000
            ],
            [
                34.64,
                1707800400
            ],
            [
                35.06,
                1707886800
            ],
            [
                35.91,
                1707973200
            ],
            [
                36.1,
                1708059600
            ],
            [
                36,
                1708405200
            ],
            [
                38.36,
                1708491600
            ],
            [
                39.72,
                1708578000
            ],
            [
                40.56,
                1708664400
            ],
            [
                39.67,
                1708923600
            ],
            [
                39.84,
                1709010000
            ],
            [
                39.69,
                1709096400
            ],
            [
                39.81,
                1709182800
            ],
            [
                41.11,
                1709269200
            ],
            [
                40.93,
                1709528400
            ],
            [
                41.41,
                1709614800
            ],
            [
                41.69,
                1709701200
            ],
            [
                41.71,
                1709787600
            ],
            [
                41.73,
                1709874000
            ],
            [
                41.2,
                1710129600
            ],
            [
                41.95,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 9578,
        "drug_name": "HYQVIA (Immune Globulin Infusion 10% with Recombinant Human Hyaluronidase)",
        "clinical_trial_id": "NCT02549170",
        "has_trial_insight_page": 0,
        "indication": "Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP)",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2024-01-16",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/TAK\/news\/180149",
        "note": "Approved January 16, 2024.",
        "company_entity_id": 751,
        "company_ticker": "TAK",
        "company_name": "Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1\/2 of a share of)",
        "company_price": "14.3700",
        "company_change": -0.19999999999999996,
        "company_percent_change": -1.37,
        "company_optionable": 1,
        "company_number_of_shares": 3137776702,
        "price_change_sparkline": [
            [
                14.6,
                1706677200
            ],
            [
                14.38,
                1706763600
            ],
            [
                14.28,
                1706850000
            ],
            [
                13.92,
                1707109200
            ],
            [
                14.16,
                1707195600
            ],
            [
                14.18,
                1707282000
            ],
            [
                14,
                1707368400
            ],
            [
                14.24,
                1707454800
            ],
            [
                14.31,
                1707714000
            ],
            [
                14.34,
                1707800400
            ],
            [
                14.54,
                1707886800
            ],
            [
                14.42,
                1707973200
            ],
            [
                14.62,
                1708059600
            ],
            [
                14.82,
                1708405200
            ],
            [
                14.74,
                1708491600
            ],
            [
                14.64,
                1708578000
            ],
            [
                14.62,
                1708664400
            ],
            [
                14.81,
                1708923600
            ],
            [
                14.84,
                1709010000
            ],
            [
                14.65,
                1709096400
            ],
            [
                14.59,
                1709182800
            ],
            [
                14.56,
                1709269200
            ],
            [
                14.48,
                1709528400
            ],
            [
                14.4,
                1709614800
            ],
            [
                14.69,
                1709701200
            ],
            [
                14.86,
                1709787600
            ],
            [
                14.77,
                1709874000
            ],
            [
                14.57,
                1710129600
            ],
            [
                14.37,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 4742,
        "drug_name": "CASGEVY (exagamglogene autotemcel [exa-cel]",
        "clinical_trial_id": null,
        "has_trial_insight_page": 0,
        "indication": "Beta-thalassemia",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2024-01-16",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/VRTX\/news\/180272",
        "note": "FDA Approved on January 16, 2024.",
        "company_entity_id": 544,
        "company_ticker": "CRSP",
        "company_name": "CRISPR Therapeutics AG",
        "company_price": "75.3000",
        "company_change": -1.52,
        "company_percent_change": -1.98,
        "company_optionable": 1,
        "company_number_of_shares": 80275950,
        "price_change_sparkline": [
            [
                62.95,
                1706677200
            ],
            [
                64.67,
                1706763600
            ],
            [
                64.75,
                1706850000
            ],
            [
                64.51,
                1707109200
            ],
            [
                66.88,
                1707195600
            ],
            [
                65.72,
                1707282000
            ],
            [
                68.83,
                1707368400
            ],
            [
                70.01,
                1707454800
            ],
            [
                76.44,
                1707714000
            ],
            [
                72.78,
                1707800400
            ],
            [
                79.04,
                1707886800
            ],
            [
                84.48,
                1707973200
            ],
            [
                82.22,
                1708059600
            ],
            [
                78.73,
                1708405200
            ],
            [
                82.41,
                1708491600
            ],
            [
                86.19,
                1708578000
            ],
            [
                83.99,
                1708664400
            ],
            [
                86.06,
                1708923600
            ],
            [
                89.12,
                1709010000
            ],
            [
                87.68,
                1709096400
            ],
            [
                84.22,
                1709182800
            ],
            [
                83.75,
                1709269200
            ],
            [
                81.74,
                1709528400
            ],
            [
                80.99,
                1709614800
            ],
            [
                80.83,
                1709701200
            ],
            [
                79.37,
                1709787600
            ],
            [
                78.92,
                1709874000
            ],
            [
                76.82,
                1710129600
            ],
            [
                75.3,
                1710216000
            ]
        ],
        "statuses": [
            {
                "label": "Fast Track Designation (FTD)",
                "abbreviation": "FTD",
                "description": "Fast Track Designation (FTD)",
                "description_html": "<p>Fast Track Designation (FTD)<\/p>\n"
            },
            {
                "label": "Orphan Drug Designation (ODD)",
                "abbreviation": "ODD",
                "description": "Orphan Drug Designation (ODD)",
                "description_html": "<p>Orphan Drug Designation (ODD)<\/p>\n"
            }
        ]
    },
    {
        "id": 4742,
        "drug_name": "CASGEVY (exagamglogene autotemcel [exa-cel]",
        "clinical_trial_id": null,
        "has_trial_insight_page": 0,
        "indication": "Beta-thalassemia",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2024-01-16",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/VRTX\/news\/180272",
        "note": "FDA Approved on January 16, 2024.",
        "company_entity_id": 306,
        "company_ticker": "VRTX",
        "company_name": "Vertex Pharmaceuticals Incorporated",
        "company_price": "412.4500",
        "company_change": -2.02,
        "company_percent_change": -0.49,
        "company_optionable": 1,
        "company_number_of_shares": 258307816,
        "price_change_sparkline": [
            [
                433.38,
                1706677200
            ],
            [
                433.87,
                1706763600
            ],
            [
                424.68,
                1706850000
            ],
            [
                428.89,
                1707109200
            ],
            [
                416.13,
                1707195600
            ],
            [
                419.08,
                1707282000
            ],
            [
                423.06,
                1707368400
            ],
            [
                422.91,
                1707454800
            ],
            [
                418.53,
                1707714000
            ],
            [
                416.04,
                1707800400
            ],
            [
                417.88,
                1707886800
            ],
            [
                426.29,
                1707973200
            ],
            [
                422.2,
                1708059600
            ],
            [
                420.64,
                1708405200
            ],
            [
                419.63,
                1708491600
            ],
            [
                426.78,
                1708578000
            ],
            [
                430.11,
                1708664400
            ],
            [
                433.48,
                1708923600
            ],
            [
                430.92,
                1709010000
            ],
            [
                426.97,
                1709096400
            ],
            [
                420.74,
                1709182800
            ],
            [
                432.76,
                1709269200
            ],
            [
                424.03,
                1709528400
            ],
            [
                415.44,
                1709614800
            ],
            [
                411.85,
                1709701200
            ],
            [
                410.54,
                1709787600
            ],
            [
                413.59,
                1709874000
            ],
            [
                414.47,
                1710129600
            ],
            [
                412.45,
                1710216000
            ]
        ],
        "statuses": [
            {
                "label": "Fast Track Designation (FTD)",
                "abbreviation": "FTD",
                "description": "Fast Track Designation (FTD)",
                "description_html": "<p>Fast Track Designation (FTD)<\/p>\n"
            },
            {
                "label": "Orphan Drug Designation (ODD)",
                "abbreviation": "ODD",
                "description": "Orphan Drug Designation (ODD)",
                "description_html": "<p>Orphan Drug Designation (ODD)<\/p>\n"
            }
        ]
    },
    {
        "id": 10071,
        "drug_name": "ZYNRELEF (bupivacaine and meloxicam) extended-release",
        "clinical_trial_id": null,
        "has_trial_insight_page": 0,
        "indication": "Soft tissue and orthopedic surgical procedures",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2024-01-23",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/HRTX\/news\/181489",
        "note": "FDA Approved on January 23, 2024.",
        "company_entity_id": 157,
        "company_ticker": "HRTX",
        "company_name": "Heron Therapeutics Inc.",
        "company_price": "2.3600",
        "company_change": -0.050000000000000044,
        "company_percent_change": -2.07,
        "company_optionable": 1,
        "company_number_of_shares": 150072640,
        "price_change_sparkline": [
            [
                2.41,
                1706677200
            ],
            [
                2.4,
                1706763600
            ],
            [
                2.39,
                1706850000
            ],
            [
                2.23,
                1707109200
            ],
            [
                2.32,
                1707195600
            ],
            [
                2.26,
                1707282000
            ],
            [
                2.35,
                1707368400
            ],
            [
                2.43,
                1707454800
            ],
            [
                2.63,
                1707714000
            ],
            [
                2.51,
                1707800400
            ],
            [
                2.72,
                1707886800
            ],
            [
                2.88,
                1707973200
            ],
            [
                2.87,
                1708059600
            ],
            [
                2.87,
                1708405200
            ],
            [
                2.75,
                1708491600
            ],
            [
                2.62,
                1708578000
            ],
            [
                2.6,
                1708664400
            ],
            [
                2.6,
                1708923600
            ],
            [
                2.74,
                1709010000
            ],
            [
                2.7,
                1709096400
            ],
            [
                2.66,
                1709182800
            ],
            [
                2.61,
                1709269200
            ],
            [
                2.555,
                1709528400
            ],
            [
                2.56,
                1709614800
            ],
            [
                2.48,
                1709701200
            ],
            [
                2.59,
                1709787600
            ],
            [
                2.6,
                1709874000
            ],
            [
                2.41,
                1710129600
            ],
            [
                2.36,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 2547,
        "drug_name": "VesiGel UGN-102 - (ENVISION)",
        "clinical_trial_id": "NCT05243550",
        "has_trial_insight_page": 1,
        "indication": "Low grade non-muscle invasive bladder cancer (LG-NMIBC)",
        "label": "NDA Filing",
        "value": "ndaFiling",
        "simplified_stage": "phase4",
        "stageid": 10,
        "stage_name": "NDA Filing",
        "date": "2024-01-24",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/URGN\/news\/181551",
        "note": "NDA was submitted to FDA on January 24, 2024",
        "company_entity_id": 412,
        "company_ticker": "URGN",
        "company_name": "UroGen Pharma Ltd.",
        "company_price": "17.6200",
        "company_change": 0.52,
        "company_percent_change": 3.04,
        "company_optionable": 1,
        "company_number_of_shares": 30866320,
        "price_change_sparkline": [
            [
                15.7,
                1706677200
            ],
            [
                15.9,
                1706763600
            ],
            [
                16.47,
                1706850000
            ],
            [
                15.99,
                1707109200
            ],
            [
                16.01,
                1707195600
            ],
            [
                16.02,
                1707282000
            ],
            [
                18.5,
                1707368400
            ],
            [
                18.98,
                1707454800
            ],
            [
                19.3,
                1707714000
            ],
            [
                18.75,
                1707800400
            ],
            [
                19.22,
                1707886800
            ],
            [
                18.8,
                1707973200
            ],
            [
                19.33,
                1708059600
            ],
            [
                19.24,
                1708405200
            ],
            [
                17.69,
                1708491600
            ],
            [
                17.79,
                1708578000
            ],
            [
                17.09,
                1708664400
            ],
            [
                17.96,
                1708923600
            ],
            [
                18.59,
                1709010000
            ],
            [
                18.17,
                1709096400
            ],
            [
                18.33,
                1709182800
            ],
            [
                17.77,
                1709269200
            ],
            [
                18.42,
                1709528400
            ],
            [
                18.01,
                1709614800
            ],
            [
                18.05,
                1709701200
            ],
            [
                18.03,
                1709787600
            ],
            [
                17.99,
                1709874000
            ],
            [
                17.1,
                1710129600
            ],
            [
                17.62,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 9562,
        "drug_name": "Dupixent (dupilumab)",
        "clinical_trial_id": null,
        "has_trial_insight_page": 0,
        "indication": "Eosinophilic esophagitis (EoE) in 1-11 year olds",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2024-01-25",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/REGN\/news\/181947",
        "note": "Approved January 25, 2024.",
        "company_entity_id": 388,
        "company_ticker": "REGN",
        "company_name": "Regeneron Pharmaceuticals Inc.",
        "company_price": "970.5700",
        "company_change": 6.13,
        "company_percent_change": 0.64,
        "company_optionable": 1,
        "company_number_of_shares": 109761896,
        "price_change_sparkline": [
            [
                942.78,
                1706677200
            ],
            [
                957.78,
                1706763600
            ],
            [
                945.18,
                1706850000
            ],
            [
                936.33,
                1707109200
            ],
            [
                937.81,
                1707195600
            ],
            [
                938.49,
                1707282000
            ],
            [
                946.43,
                1707368400
            ],
            [
                953.42,
                1707454800
            ],
            [
                947.06,
                1707714000
            ],
            [
                940.48,
                1707800400
            ],
            [
                947.82,
                1707886800
            ],
            [
                954.73,
                1707973200
            ],
            [
                948.05,
                1708059600
            ],
            [
                946.87,
                1708405200
            ],
            [
                952.84,
                1708491600
            ],
            [
                964.89,
                1708578000
            ],
            [
                981.2,
                1708664400
            ],
            [
                989.28,
                1708923600
            ],
            [
                993.35,
                1709010000
            ],
            [
                987.61,
                1709096400
            ],
            [
                966.09,
                1709182800
            ],
            [
                982.82,
                1709269200
            ],
            [
                971.19,
                1709528400
            ],
            [
                965.21,
                1709614800
            ],
            [
                972.1,
                1709701200
            ],
            [
                973.31,
                1709787600
            ],
            [
                968.83,
                1709874000
            ],
            [
                964.44,
                1710129600
            ],
            [
                970.57,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 9562,
        "drug_name": "Dupixent (dupilumab)",
        "clinical_trial_id": null,
        "has_trial_insight_page": 0,
        "indication": "Eosinophilic esophagitis (EoE) in 1-11 year olds",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2024-01-25",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/REGN\/news\/181947",
        "note": "Approved January 25, 2024.",
        "company_entity_id": 389,
        "company_ticker": "SNY",
        "company_name": "Sanofi",
        "company_price": "48.4600",
        "company_change": 0.11,
        "company_percent_change": 0.23,
        "company_optionable": 1,
        "company_number_of_shares": 2529599938,
        "price_change_sparkline": [
            [
                49.9,
                1706677200
            ],
            [
                48.41,
                1706763600
            ],
            [
                47.23,
                1706850000
            ],
            [
                46.95,
                1707109200
            ],
            [
                47.06,
                1707195600
            ],
            [
                46.92,
                1707282000
            ],
            [
                46.56,
                1707368400
            ],
            [
                46.5,
                1707454800
            ],
            [
                46.34,
                1707714000
            ],
            [
                45.75,
                1707800400
            ],
            [
                45.8,
                1707886800
            ],
            [
                46.39,
                1707973200
            ],
            [
                46.18,
                1708059600
            ],
            [
                46.85,
                1708405200
            ],
            [
                47.92,
                1708491600
            ],
            [
                47.8,
                1708578000
            ],
            [
                48.77,
                1708664400
            ],
            [
                48.2,
                1708923600
            ],
            [
                48.21,
                1709010000
            ],
            [
                48,
                1709096400
            ],
            [
                47.85,
                1709182800
            ],
            [
                47.29,
                1709269200
            ],
            [
                47.15,
                1709528400
            ],
            [
                47.5,
                1709614800
            ],
            [
                47.68,
                1709701200
            ],
            [
                48.06,
                1709787600
            ],
            [
                48.25,
                1709874000
            ],
            [
                48.35,
                1710129600
            ],
            [
                48.46,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 11130,
        "drug_name": "GAMMAGARD LIQUID [Immune Globulin Infusion (Human) 10% solution]",
        "clinical_trial_id": null,
        "has_trial_insight_page": 0,
        "indication": "Adults with chronic inflammatory demyelinating polyneuropathy (CIDP)",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2024-01-29",
        "link": "https:\/\/www.biopharmcatalyst.com\/company\/TAK\/news\/182365",
        "note": "FDA Approved on January 29, 2024.",
        "company_entity_id": 751,
        "company_ticker": "TAK",
        "company_name": "Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1\/2 of a share of)",
        "company_price": "14.3700",
        "company_change": -0.19999999999999996,
        "company_percent_change": -1.37,
        "company_optionable": 1,
        "company_number_of_shares": 3137776702,
        "price_change_sparkline": [
            [
                14.6,
                1706677200
            ],
            [
                14.38,
                1706763600
            ],
            [
                14.28,
                1706850000
            ],
            [
                13.92,
                1707109200
            ],
            [
                14.16,
                1707195600
            ],
            [
                14.18,
                1707282000
            ],
            [
                14,
                1707368400
            ],
            [
                14.24,
                1707454800
            ],
            [
                14.31,
                1707714000
            ],
            [
                14.34,
                1707800400
            ],
            [
                14.54,
                1707886800
            ],
            [
                14.42,
                1707973200
            ],
            [
                14.62,
                1708059600
            ],
            [
                14.82,
                1708405200
            ],
            [
                14.74,
                1708491600
            ],
            [
                14.64,
                1708578000
            ],
            [
                14.62,
                1708664400
            ],
            [
                14.81,
                1708923600
            ],
            [
                14.84,
                1709010000
            ],
            [
                14.65,
                1709096400
            ],
            [
                14.59,
                1709182800
            ],
            [
                14.56,
                1709269200
            ],
            [
                14.48,
                1709528400
            ],
            [
                14.4,
                1709614800
            ],
            [
                14.69,
                1709701200
            ],
            [
                14.86,
                1709787600
            ],
            [
                14.77,
                1709874000
            ],
            [
                14.57,
                1710129600
            ],
            [
                14.37,
                1710216000
            ]
        ],
        "statuses": []
    }
]